← COMPASS Pathways plc
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Revenue | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Net Interest Income | — | — | — | $0 | $2.4m |
$3.8m
+56.63%
|
$2.7m
-29.66%
|
$3.9m
+45.25%
|
|
| Research and development | $12.6m | $23.4m | $44.0m | $65.1m | $87.5m | $119.0m | $118.4m | $112.9m | |
| General and administrative | $8.4m | $27.9m | $39.2m | $45.4m | $49.4m | $59.2m | $60.6m | $68.9m | |
| General and administrative - fees due to a related party | $226k | $165k | — | — | — | — | — | — | |
| Operating Expenses | $21.2m | $51.4m | $83.2m | $110.4m | $136.9m | $178.2m | $179.0m | $185.7m | |
| LOSS FROM OPERATIONS: | ($21.2m) | ($51.4m) | |||||||
| Operating Income (Loss) | ($21.2m) |
($51.4m)
-142.66%
|
($83.2m)
-61.93%
|
($110.4m)
-32.66%
|
($136.9m)
-24.02%
|
($178.2m)
-30.15%
|
($179.0m)
-0.47%
|
($185.7m)
-3.72%
|
|
| Interest Expense, Debt | — | — | — | — | $2.2m | $4.5m | $4.5m | $5.2m | |
| Interest Income | — | — | — | — | $4.6m | $8.3m | $7.2m | $9.1m | |
| Net Non Operating Interest Income Expense | — | — | — | $0 | $2.4m | $3.8m | $2.7m | $3.9m | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | ($1.1m) | ($1.8m) | $0 | $0 | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($81k) | ($11.7m) | $2.0m | $821k | $3.7m | ($1.0m) | $3.5m | — | |
| Gain On Sale Of Security | — | — | — | $821k | $3.7m | ($1.0m) | ($119.1m) | ($216.8m) | |
| Other income, net | $73k | $319k | — | — | — | — | — | ($215.0m) | |
| Other Nonoperating Income (Expense) | — | — | — | $4.1m | $255k | $823k | $1.4m | — | |
| Interest Expense (non-operating) | — | — | — | $0 | $2.2m | $4.5m | $4.5m | $5.2m | |
| Other Income Expense | — | — | — | $4.9m | $3.9m | ($209k) | ($117.7m) | ($215.0m) | |
| Total other income (expense), net | $1.6m | ($8.9m) | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | ($72.4m) | ($92.8m) | ($120.3m) | ($156.7m) | ($293.9m) | ($396.8m) | |
| Loss before income taxes | ($19.6m) | ($60.3m) | — | — | — | — | — | — | |
| Pre-Tax Income | — | — | ($71.5m) | ($91.1m) | ($117.7m) | ($153.5m) | ($290.3m) | ($396.8m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | ($71.5m) | ($91.1m) | ($117.7m) | ($153.5m) | ($290.3m) | ($396.8m) | |
| Current Income Tax Expense (Benefit) | $15k | $253k | $744k | $1.9m | $1.9m | $2.0m | ($2.5m) | ($2.6m) | |
| Income tax expense | ($15k) | ($32k) | $199k | $408k | $780k | $1.6m | $2.5m | ($2.6m) | |
| Net loss | ($19.6m) | ($60.3m) | — | — | — | — | — | — | |
| Net Income From Continuing And Discontinued Operation | ($19.6m) | ($60.3m) | ($71.7m) | ($91.5m) | ($118.5m) | ($155.1m) | ($287.9m) | ($394.2m) | |
| Earnings Per Share, Basic | ($2.62) | ($3.55) | ($1.79) | ($2.16) | ($2.32) | ($2.30) | ($3.08) | ($3.79) | |
| Earnings Per Share, Diluted | ($2.62) | ($3.55) | ($1.79) | ($2.16) | ($2.32) | ($2.30) | ($3.08) | ($3.79) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | 40.0m | 42.4m | 51.0m | 67.5m | 93.5m | 109.2m | |
| Weighted average ordinary shares outstanding—basic and diluted (in shares) | 7.5m | 17.0m | — | — | — | — | — | — | |
| Basic Average Shares | — | — | — | $42.4m | $67.5m | $67.5m | $93.5m | $109.2m | |
| Diluted Average Shares | — | — | — | $42.4m | $67.5m | $67.5m | $93.5m | $109.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 40.0m | 42.4m | 51.0m | 67.5m | 93.5m | 109.2m | |
| Additional Financial Items | |||||||||
| Foreign exchange losses | ($81k) | ($11.7m) | — | — | — | — | — | — | |
| Fair value change of convertible notes | ($670k) | ($1.0m) | — | — | — | — | — | — | |
| Fair value change of convertible notes - due to a related party | ($469k) | ($730k) | — | — | — | — | — | — | |
| Benefit from R&D tax credit | $2.7m | $4.2m | — | — | — | — | — | — | |
| Foreign exchange translation adjustment | $337k | $14.7m | — | — | — | — | — | — | |
| Comprehensive loss | ($19.3m) | ($45.7m) | — | — | — | — | — | — | |
| Diluted EPS | ($2.62) | ($3.55) | ($1.79) | ($2.16) | ($2.32) | ($2.30) | ($3.08) | ($3.79) | |
| Diluted NI Availto Com Stockholders | ($19.6m) | ($60.3m) | ($71.7m) | ($91.5m) | ($118.5m) | ($155.1m) | ($287.9m) | ($394.2m) | |
| Normalized EBITDA | — | — | — | ($91.6m) | ($118.9m) | ($147.8m) | ($166.5m) | ($391.6m) | |
| Normalized Income | — | — | — | ($92.2m) | ($121.4m) | ($154.3m) | ($169.8m) | ($178.8m) | |
| Other Gand A | — | — | — | $22.4m | $22.8m | $26.5m | $32.4m | — | |
| Other Taxes | — | — | — | ($14.4m) | ($12.9m) | ($21.1m) | ($3.7m) | $3.9m | |
| Reconciled Depreciation | — | — | — | $330k | $242k | $233k | $216k | $21k | |
| Salaries And Wages | — | — | — | $22.9m | $26.6m | $32.6m | $28.2m | $32.6m | |
| Selling General And Administration | $8.4m | $27.9m | $39.2m | $45.4m | $49.4m | $59.2m | $60.6m | — | |
| Tax Effect Of Unusual Items | — | — | — | $156k | $700k | ($258k) | ($1.0m) | ($1.4m) | |
| Tax Provision | — | — | — | $408k | $780k | $1.6m | ($2.5m) | ($2.6m) | |
| Tax Rate For Calcs | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Operating Expense | — | — | — | $96.0m | $124.0m | $157.1m | $175.3m | $185.7m | |
| Total Unusual Items | — | — | — | $821k | $3.7m | ($1.0m) | ($119.1m) | ($216.8m) | |
| Total Expenses | — | — | — | $96.0m | $124.0m | $157.1m | $175.3m | $185.7m |